Insulin resistance and hypertension in patients with type 1 diabetes

Juan J Chillarón1, María P Sales, Juana A Flores-Le-Roux

  • 1Department of Endocrinology, Hospital del Mar, Barcelona, Spain.

Insights

Hypertension affects nearly one-third of type 1 diabetes patients, particularly men and those with longer diabetes duration. Lower insulin sensitivity and kidney complications significantly increase hypertension risk in this population.

Area of Science:

  • Endocrinology
  • Cardiovascular Health
  • Metabolic Disorders

Background:

  • Type 1 diabetes (T1D) is a chronic autoimmune condition characterized by insulin deficiency.
  • Hypertension is a significant comorbidity in T1D, increasing the risk of cardiovascular and renal complications.
  • Understanding the prevalence and associated factors of hypertension in T1D is crucial for effective management.

Purpose of the Study:

  • To determine the prevalence of hypertension in patients with type 1 diabetes.
  • To investigate the relationship between hypertension, insulin resistance, and other clinical factors in T1D.
  • To identify independent predictors of hypertension in individuals with T1D.

Main Methods:

  • A cross-sectional study involving 291 Caucasian patients aged 18+ with T1D duration >6 months.
  • Hypertension defined as blood pressure ≥130/80 mmHg or use of antihypertensive medication.
  • Insulin sensitivity assessed using estimated glucose disposal rate (eGDR).

Main Results:

  • Hypertension was identified in 29.9% of T1D patients.
  • Hypertensive patients were older, predominantly male, with higher BMI and longer diabetes duration.
  • Lower insulin sensitivity (eGDR) and nephropathy were independently associated with increased hypertension prevalence.

Conclusions:

  • Approximately one-third of T1D patients have hypertension, linked to male sex, microangiopathy, obesity, older age, and longer diabetes duration.
  • Hypertension prevalence escalates with renal impairment severity.
  • Insulin sensitivity is inversely related to hypertension in type 1 diabetes.
Abstract

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...